Monell Chemical Senses Center
24
1
2
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 24 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
15%
3 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (24)
Impact of Smell Testing on Health Outcomes
Role: lead
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
Role: lead
Monell USDA Taste Test Study
Role: collaborator
Snacks, Smiles and Taste Preferences
Role: collaborator
Sensory Evaluation of the Taste of Pediatric Medicines
Role: lead
Ibuprofen Inhibits Human Sweet Taste
Role: collaborator
Taste of Medicines in Children
Role: collaborator
Added Sugar Intake, Sweet Taste Phenotypes and Biomarkers
Role: lead
"Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction.
Role: collaborator
Sensory Analysis and Taste Modulation of Ketone Esters
Role: lead
Sensitive Periods in Human Flavor Learning
Role: lead
Effect of Infant Formula on Energy Balance
Role: lead
Shifting Salty Taste Preferences in Children
Role: lead
Allele-specific Expression of a Bitter Taste Receptor
Role: lead
Effects of Infant Formula Composition on Infant Feeding Behaviors
Role: lead
The Molecular Basis for a Broad Range of Phenotypes Related to hTAS2R38
Role: lead
Genetic Variability in Taste Perception
Role: lead
Efficacy of Bitter Blockers on Taste Perception in Children and Adults
Role: lead
CD36 and Human Fat Taste Perception
Role: collaborator
Taste Preferences for Nutritive and Non Nutritive Sweeteners Among Children and Adults
Role: lead